This is a $600,000 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Integral Molecular Inc., a biotechnology company specializing in membrane protein research and therapeutic antibody development. The contract is for the development of "Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models", supporting NIAID's mission in infectious disease research. This contract is a total small business set-aside, as Integral Molecular is a for-profit organization that meets the SBIR size and ownership requirements. The work aligns with Integral Molecular's expertise in providing biomedical research services and products to federal agencies including NIH, CDC, and the Department of the Army.
Generated 12/3/24, 9:58 AM